NABIP Seeks Injunctive Relief Against HHS and CMS over Marketplace Moratorium Affecting Nearly 19,000 Agents and Brokers
Washington, D.C.--(Newsfile Corp. - October 15, 2026) - The National Association of Benefits and Insurance Professionals (NABIP) today filed suit against the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), challenging a new rule and policy that, together, prevent thousands of health insurance agents and brokers from participating in the federally facilitated Affordable Care Act (ACA) Marketplace during the Open Enrollment period beginn
Healthcare and Hospitals, Insurance
2026-10-15 4:20 PM EDT | National Association of Benefits and Insurance Professionals (NABIP)
Extendicare Announces October 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - October 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of October 2026, which is payable on November 16, 2026 to shareholders of record at the close of business on October 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare
Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-15 8:00 AM EDT | Extendicare Inc.
HEALWELL AI Named to TIME's World's Top HealthTech Companies of 2026 and Announces 12 Real-World Evidence and Clinical AI Presentations at International Conferences This Fall.
Toronto, Ontario--(Newsfile Corp. - October 15, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQ
Technology, Healthcare and Hospitals
2026-10-15 6:00 AM EDT | HEALWELL AI
medmix Launches MIXPAC(TM) PiccoMix(TM) to Advance Efficiency and Sustainability in Dental Cementation Delivery
Baar, Switzerland--(Newsfile Corp. - October 15, 2026) - medmix introduces the new MIXPAC™ PiccoMix™ mixing tip, a next-generation solution for dental cementation delivery designed to help dental
Technology, Construction / Building, Healthcare and Hospitals, Household / Consumer / Cosmetics
2026-10-15 3:08 AM EDT | medmix AG
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position
Winter Park, Florida--(Newsfile Corp. - October 13, 2026) - Adia Med, Inc. (OTCQB: ADIA) (the "Company") today announced the full repayment and discharge of its unsecured revolving line of credit with Larry Powalisz, the Company's Chief Executive Officer.
Healthcare and Hospitals, Health
2026-10-13 9:00 AM EDT | Adia Med Inc.
Phio Pharmaceuticals Announces Successful Completion of First Commercial-Scale cGMP Batch of PH-762 Drug Substance
King of Prussia, Pennsylvania--(Newsfile Corp. - October 13, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced the successful release of its first commercial-scale cGMP batch of PH-762 drug substance (active pharmaceutical ingredient), representing a critical operational and strategic milestone as the Company advances PH-762 to the next
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-13 7:00 AM EDT | Phio Pharmaceuticals Corp.
Discovery Senior Living to Participate in 2026 NIC Fall Conference
Bonita Springs, Florida--(Newsfile Corp. - October 12, 2026) - Discovery Senior Living ("Discovery" or "the Company) the largest seniors housing operator in US, and its affiliated management companies, is pleased to announce its participation in the 2026 NIC Fall Conference, taking place October 21-23 in Chicago, Illinois. Connect with Discovery at NIC 2026! Discovery's executive leadership team will be on-site throughout the conference, engaging
Healthcare and Hospitals, Real Estate, Housing
2026-10-12 10:06 PM EDT | Discovery Senior Living
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fu
Biotechnology, Healthcare and Hospitals
2026-10-12 8:30 AM EDT | Envoy Medical, Inc.
Theralase(R) to Present at ThinkEquity Conference
Toronto, Ontario--(Newsfile Corp. - October 9, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of proprietary Energy-Activated Small Molecules ("EASMs") for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the Company has been invited to present at the 2026 Thin
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-10-09 7:00 AM EDT | Theralase Technologies Inc.
Discovery Senior Living Appoints LakeHouse Senior Living President
Bonita Springs, Florida--(Newsfile Corp. - October 8, 2026) - Discovery Senior Living ("Discovery" or "the Company) the largest seniors housing operator in US, and its affiliated management companies, is pleased to announce the appointment of Brad Poterack to President of LakeHouse Senior Living ("LakeHouse"), recognizing the management company's sustained growth and operating performance under his leadership as Chief Operating Officer.
Healthcare and Hospitals, Real Estate, Housing
2026-10-08 12:50 PM EDT | Discovery Senior Living
Enoumena Therapeutics and AOP Health Announce Exclusive Canadian Commercialization Agreement for SIBBORAN(R) (landiolol)
Quebec and Vienna, Austria--(Newsfile Corp. - October 8, 2026) - Enoumena Therapeutics Inc. and AOP Health today announced an exclusive commercialization agreement to expand Canadian institutional access to PrSIBBORAN® (landiolol hydrochloride), an ultra-short-acting, selective beta-1 adrenergic receptor blocker. Authorized by Health Canada in 2023, SIBBORAN is indicated for the short-term reduction of ventricular rate in patients with supraventricular tachycar
Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-10-08 10:47 AM EDT | Enoumena Therapeutics Inc.
Enoumena Therapeutics et AOP Health annoncent une entente exclusive de commercialisation au Canada de SIBBORAN(R) (landiolol)
Québec et Vienne, Autriche--(Newsfile Corp. - 8 octobre 2026) - Enoumena Therapeutics Inc. et AOP Health ont annoncé aujourd'hui la conclusion d'une entente exclusive de commercialisation visant à élargir l'accès des établissements de santé canadiens à PrSIBBORAN® (chlorhydrate de landiolol), un bêtabloquant sélectif des récepteurs bêta-1 adrénergiques à action ultra-courte. Autorisé par Sant
Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-10-08 10:47 AM EDT | Enoumena Therapeutics Inc.
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Nova Scotia
New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - October 7, 2026) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced that the Breast Health Research Unit (BHRU) at IWK Health has joined as the second Canadian site in its large multi-center observational data collection study to advan
Technology, Biotechnology, Healthcare and Hospitals, Health
2026-10-08 10:01 AM EDT | Breathe BioMedical Inc.
Illumisoft Appoints Former 3M Growth Ventures Leader Bill Weber as Chief Strategy Officer
Vancouver, British Columbia--(Newsfile Corp. - October 8, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") announces the appointment of Bill Weber as Chief Strategy Officer, effective October 7, 2026. Mr. Weber will work with Chief Executive Officer Ehsan Agahi and the leadership team on corporate strategy, commercial priorities, strategic partnerships and market development as Illumisoft advances commercialization of its SaniLume upper-room
Technology, Biotechnology, Healthcare and Hospitals, Household / Consumer / Cosmetics
2026-10-08 9:27 AM EDT | Illumisoft Lighting Corp.
Simple Eye Test and Glasses Could Help Double a Child's Lifetime Earnings in Both the USA and Canada
New IAPB finding shows a child's lifetime earnings could double in total of 23 countries worldwide if vision problems are identified and corrected early "A simple eye test and glasses could be one of the best investments a parent can make" IAPB CEO Finding published on World Sight Day, as governments urged to ensure every child has access to sight tests and glasses
Education, Healthcare and Hospitals, Pharmaceuticals
2026-10-08 9:00 AM EDT | International Agency for the Prevention of Blindness
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Nova Scotia
New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - October 7, 2026) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced that the Breast Health Research Unit (BHRU) at IWK Health has joined as the second Canadian site in its large multi-center observational data collection study to advan
Technology, Biotechnology, Healthcare and Hospitals, Health
2026-10-07 8:00 AM EDT | Breathe BioMedical Inc.
Palindrome Pharma Launches in Canada to Unlock Access to High-Quality Biosimilar Medicines
Toronto, Ontario--(Newsfile Corp. - October 7, 2026) - Palindrome Pharma, a new pharmaceutical company focused on biosimilar medicines, today announced its launch in Canada, with a mission to broaden access to high-quality biologic therapies and contribute to a more sustainable Canadian healthcare system. As demand for biologic medicines continues to grow, biosimilars have an important role to play in creating greater choices for Canadians. Palindrome Pharma will work with global and C
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-07 12:30 AM EDT | Palindrome Pharma Inc.
Optima Living, Axium Infrastructure and Desjardins Global Asset Management Announce Acquisition of Five Seniors Living and Continuing Care Communities from The Brenda Strafford Foundation
Edmonton, Alberta--(Newsfile Corp. - October 6, 2026) - Optima Living ("Optima" or "Optima Living"), Axium Infrastructure, via one of its managed funds ("Axium"), and DGAM Global Private Infrastructure Fund ("DGAM Infrastructure Fund") managed by Desjardins Global Asset Management Inc., are pleased to announce the acquisition of five seniors living and continuing care communities from The Brenda Strafford Foundation ("BSF") in Calgary and Okotoks, Alberta: Bow View Manor, Cambridge Manor, Cl
2026-10-06 10:00 AM EDT | Optima Seniors Management Inc.
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
Winter Park, Florida--(Newsfile Corp. - October 6, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has sold a 30% interest in Adia Labs LLC to Live Oak Health, a stem cell distributor doing business as QCM Biologics, for $1.5 million, and that the sale is paired with a distribution partnership. The Company has filed a Form 8-K related to the transaction. Link to Form 8-K here: Inline Viewer: ADIA MED, INC. 8-K 2026-
Healthcare and Hospitals, Health
2026-10-06 9:20 AM EDT | Adia Med Inc.
Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - October 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced that Robert Bi
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-10-06 7:00 AM EDT | Phio Pharmaceuticals Corp.